| Literature DB >> 26473931 |
Justyna K Laba1,2, Anton Steen3, Petra Popken1,2, Alina Chernova4,5, Bert Poolman2, Liesbeth M Veenhoff6.
Abstract
It is poorly understood how membrane proteins destined for the inner nuclear membrane pass the crowded environment of the Nuclear Pore Complex (NPC). For the Saccharomyces cerevisiae proteins Src1/Heh1 and Heh2, a transport mechanism was proposed where the transmembrane domains diffuse through the membrane while the extralumenal domains encoding a nuclear localization signal (NLS) and intrinsically disordered linker (L) are accompanied by transport factors and travel through the NPC. Here, we validate the proposed mechanism and explore and discuss alternative interpretations of the data. First, to disprove an interpretation where the membrane proteins become membrane embedded only after nuclear import, we present biochemical and localization data to support that the previously used, as well as newly designed reporter proteins are membrane-embedded irrespective of the presence of the sorting signals, the specific transmembrane domain (multipass or tail anchored), independent of GET, and also under conditions that the proteins are trapped in the NPC. Second, using the recently established size limit for passive diffusion of membrane proteins in yeast, and using an improved assay, we confirm active import of polytopic membrane protein with extralumenal soluble domains larger than those that can pass by diffusion on similar timescales. This reinforces that NLS-L dependent active transport is distinct from passive diffusion. Thirdly, we revisit the proposed route through the center of the NPC and conclude that the previously used trapping assay is, unfortunately, poorly suited to address the route through the NPC, and the route thus remains unresolved. Apart from the uncertainty about the route through the NPC, the data confirm active, transport factor dependent, nuclear transport of membrane-embedded mono- and polytopic membrane proteins in baker's yeast.Entities:
Keywords: inner nuclear membrane; nuclear envelope; nuclear pore complex; nuclear transport
Year: 2015 PMID: 26473931 PMCID: PMC4695851 DOI: 10.3390/cells4040653
Source DB: PubMed Journal: Cells ISSN: 2073-4409 Impact factor: 6.600
Strains.
| Name | Genotype | Source |
|---|---|---|
| K14708 | W303, Matα | [ |
| Nup170FRB | K14708, | This study |
| Nup53FRB | K14708, | This study |
| Nup59FRB | K14708, | This study |
| Kap95AA | K14708, | [ |
| BY4742 | MATα | invitrogen |
| GET1Δ | BY4742 | invitrogen |
| GET2Δ | BY4742 | invitrogen |
| GET3Δ | BY4742 | invitrogen |
Plasmids.
| No. | Name | Description | Source |
|---|---|---|---|
| 1 | pACM023-G-NLS-L-TM | GFP-Heh2 (93-378) under GAL1 promoter (HIS, Cen) | [ |
| 2 | pJKL01-F-G-NLS-L-TM | 2× FKBP12 is N-terminally fused to GFP-Heh2 (93-378) from 1 | [ |
| 3 | pJKL02-PrA-F-G-NLS-L-TM | PrA is | [ |
| 4 | pJKL03 F-G-ΔNLS-L-TM | 2× FKBP12 is N-terminally fused to Heh2 (138-378) under GAL1 promoter (HIS, Cen) | This study |
| 5 | pJKL04 F-G-NLS-ΔL-TM | As in 2, but sequence (140-302) was removed from Heh2 | This study |
| 6 | pJKL05 F-G-NLS-L-TM-SN | SNAP tag is C-terminally fused to F-G-NLS-L-TM from 2 | This study |
| 7 | pJKL06 G-NLS-L-TM-F | 2× FKBP12 is C-terminally fused to GFP-Heh2 (93-378) | This study |
| 8 | pACM040 M-G-NLS-L-TM | As in 1, Heh2 (93-378) N-terminally fused to | [ |
| 9 | pACM041 M-G-M-NLS-L-TM | As in 1, Heh2 (93-378) N-terminally fused to | [ |
| 10 | pACM042 M-G-M-M-NLS-L-TM | As in 1, Heh2 (93-378) N-terminally fused to MalE-GFP-MalE-MalE | [ |
| 11 | pAS12 M-G-NLS-L-Sec61TMA | As in 8, Heh2 TM1 replaced by Sec61 transmembrane domain | This study |
| 12 | pAS13 M-G-M-NLS-L-Sec61TMA | As in 9, Heh2 TM1 replaced by Sec61 transmembrane domain | This study |
| 13 | pAS14 M-G-M-M-NLS-L-Sec61TMA | As in 10, Heh2 TM1 replaced by Sec61 transmembrane domain | This study |
| 14 | pSI6 G-NLS-L-Sec61TMA | As in 1, Heh2 TM1 replaced by Sec61 transmembrane domain | This study |
| 15 | pACH1 G-NLS-L-RibU | As in 1, Heh2 TM1 replaced by RibU | This study |
| 16 | pACH2 M-G-NLS-L-RibU | As in 8, Heh2 TM1 replaced by RibU | This study |
| 17 | pACH3 M-G-M-M-NLS-L-RibU | As in 10, Heh2 TM1 replaced by RibU | This study |
| 18 | pACM045 G-NLS-L-Sec61TM1 | As in 8, Heh2 TM1 replaced by Sec61 first transmembrane helix | [ |
| 19 | pAK36 | mCherry-WALP-HDEL; a fusion of mCherry to an ER marker protein under Gal1 promoter (URA, Cen) | [ |
Figure 1Heh2-derived reporter proteins localizing to the NE-ER network are membrane embedded. (A) Cartoons showing domain composition of native Heh2 and derived reporters. F: FKBP (FK506 binding protein); G: GFP; SN: SNAP-tag; PrA: ProteinA. (B) Confocal fluorescence microscopy images showing K14708 cells expressing the indicated Heh2-derived reporters. Scale bars: 2 μm. (C) Western blot (anti-FKBP) of whole cells extracts of cells expressing the indicated reporters; equal protein amounts were loaded. (D) Western Blots showing the results from salt and detergent extraction of crude yeast membranes fractions. Crude membranes are incubated in control buffer (20 mM Tris with 150 mM NaCl), or in buffer with 1 M NaCl or 1% Triton and ultracentrifuged, as described in Materials and Methods. The pellet (P) and supernatant (S) fractions were loaded onto the gel. The cytoplasm fraction represents the proteins present in the supernatant of the lysate after the first centrifugation step.
Figure 3Heh2-derived reporters are membrane-embedded while transiting the NPC. (A) Confocal fluorescence microscopy images of cells expressing FRB (FKBP12-rapamycin binding)-tagged Nup170 (Nup170FRB) and F-G-NLS-L-TM reporter after incubation with rapamycin (+rap 10 μg/mL) and in control conditions (+DMSO). The fluorescence patterns change from continues to punctate upon rapamycin treatment. Scale bars: 2 μm. (B) Line-scans of the fluorescence intensity in the NE of the representative cells expressing F-G-NLS-L-TM after incubation with rapamycin (black line, +rap) or in control conditions (grey line, no rap). Top panel: control K14708 strain. Bottom panel: Nup170FRB strain. (C) Comparison of the average SD fraction for each reporter in the Nup170FRB strain (n = 37 cells for both conditions) and in the wild type (K14708, n = 7 cells for no rap, n = 55 cells for +rap); standard deviation is indicated. The SD fraction is calculated from the standard deviation of the fluorescence intensity along the NE in a cell divided by the average fluorescence intensity at the NE in that cell. (D) Western Blots showing the results from salt and detergent extraction of crude yeast membranes fractions of cells expressing Nup170FRB and F-G-NLS-L-TM. Membrane extractions were performed in trapped (+rap) and in non-trapped (+DMSO) conditions. F-G-NLS-L-TM solubilizes with the buffer with 1% Triton both in trapped and non-trapped conditions. Nup170FRB is salt-soluble before trapping and becomes salt-resistant upon trapping as the bands of solubilized fractions treated with control buffer and 1 M NaCl disappear.
Figure 5The reporters without the NLS or the linker domain can enter the NPC. (A) Confocal fluorescence microscopy images showing cells expressing F-G-NLS-L-TM in Nup53FRB and Nup59FRB strains background after incubation with rapamycin (+rap 10 μg/mL) and in control conditions (+DMSO). The fluorescence patterns change from continues to punctate upon rapamycin treatment (B,C). Same as (A), but with cells expressing F-G-ΔNLS-L-TM (B) or F-G-NLS-ΔL-TM (C) in Nup170FRB, Nup53FRB and Nup59FRB strain background. The fluorescence signal disappears from the ER upon rapamycin treatment. Scale bars: 2 μm.
Figure 2Membrane insertion of the G-NLS-L-TM reporter is GET-independent. (A) Fluorescence microscopy of wild type and get1Δ, get2Δ and get3Δ mutant yeasts expressing G-NLS-L-TM or G-NLS-L-Sec61TM1. Scale bars: 2 μm. (B) Expression levels (anti-GFP Western blot) of G-NLS-L-TM and G-NLS-L-Sec61TM1 in WT and GET mutants. (C) Western Blots (anti-GFP) showing the results form salt and detergent extraction assay on WT and get3Δ mutant expressing G-NLS-L-TM. Crude membrane preparations were treated as described in Material and Methods and in the legend to Figure 1. P, pellet; S, supernatant.
Figure 4NE accumulation of membrane protein reporters with extralumenal domains of increasing size. (A) Fluorescence microscopy of cells expressing G-NLS-L-RibU, MG-NLS-L-RibU, MGM2-NLS-L-RibU. M: MBP. (B) Average accumulation of reporter proteins at the NE over the ER after different regimes of expression, and import inhibition. The reporter proteins were expressed for 1 h (striped bars); subsequently expression was inhibited by glucose for 1 h (grey bars) and finally import was blocked by rapamycin for 1 h (white bars). Alternatively, transcription and import were inhibited simultaneously (black bars). Average of 20 cells; SEM are indicated. (C) Viability of cells expressing membrane proteins with different transmembrane domains and differently-sized extralumenal domains. (D) Western blot (anti-GFP) showing expression of the membrane protein transporters with different transmembrane domains and differently-sized extralumenal domains used in this figure.
Figure 6Analysis of the fluorescence images from Figure 5. (A) Comparison of the average SD fraction (as in Figure 3C) for F-G-NLS-L-TM, F-G-ΔNLS-L-TM, F-G-NLS-ΔL-TM in all the trap strains (Nup53FRB, Nup59FRB, Nup170FRB) and the background strain (K14708). Grey columns, control conditions (no rap); columns with black diagonal stripes, cells incubated with rapamycin (+rap). Number of cells analyzed is between 29 and 55. (B) Percentage of cells expressing F-G-ΔNLS-L-TM or F-G-NLS-ΔL-TM that display fluorescence in the ER in the trap strains (Nup53FRB, Nup59FRB, Nup170) and the background strain (K14708). The number of cells analyzed is between 31 and 158.